---
figid: PMC2921256__btt-4-187f1
figlink: /pmc/articles/PMC2921256/figure/f1-btt-4-187/
number: Figure 1
caption: Biology of the von Hippel-Lindau/hypoxia-inducible factor (VHL-HIF) axis
  in the setting of hypoxia or a mutation or aberration of the VHL gene product. In
  normoxic conditions, HIFα is hydroxylated on specific proline residues by prolyl-hydroxylases.
  VHL acts as the sensor for these hydroxylated proline residues as part of the VHL-E3
  ubiquitin ligase. This polyubiquitinates HIFα and marks it for degradation by the
  proteasome. In hypoxic conditions (or in the presence of aberrant VHL), HIFα is
  allowed to accumulate in the cell. It associates with HIFβ and this complex translocates
  to the nucleus and acts as a transcription factor binding to hypoxia response elements
  and upregulating oxygen-sensitive genes. These HIF-responsive genes include vascular
  endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), transforming
  growth factor alpha (TGFα), glucose transporter-1 (GLUT1), carbonic anhydrase IX
  (CA-IX), erythropoietin (EPO), and others. Examples of selected receptors are given,
  including VEGF receptor (VEGFR), PDGF receptor (PDGFR), and the receptor for TNFα
  and epidermal growth factor receptor (EGFR). Shown is the downstream signaling for
  one of these receptors, VEGFR, including through the PI3 kinase (PI3K)/AKT/mTOR,
  p38 MAP kinase (p38MAPK), and RAS/RAF/MEK/ERK pathways. Examples of agents (including
  pazopanib) that impact on this cascade are given, and where they act on the pathway
  is shown.
pmcid: PMC2921256
papertitle: Rationale for targeted therapies and potential role of pazopanib in advanced
  renal cell carcinoma.
reftext: Peter E Clark. Biologics. 2010;4:187-197.
pmc_ranked_result_index: '123526'
pathway_score: 0.9127015
filename: btt-4-187f1.jpg
figtitle: Biology of the von Hippel-Lindau/hypoxia-inducible factor (VHL-HIF) axis
  in the setting of hypoxia or a mutation or aberration of the VHL gene product
year: '2010'
organisms: Homo sapiens
ndex: 82f88fab-df10-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2921256__btt-4-187f1.html
  '@type': Dataset
  description: Biology of the von Hippel-Lindau/hypoxia-inducible factor (VHL-HIF)
    axis in the setting of hypoxia or a mutation or aberration of the VHL gene product.
    In normoxic conditions, HIFα is hydroxylated on specific proline residues by prolyl-hydroxylases.
    VHL acts as the sensor for these hydroxylated proline residues as part of the
    VHL-E3 ubiquitin ligase. This polyubiquitinates HIFα and marks it for degradation
    by the proteasome. In hypoxic conditions (or in the presence of aberrant VHL),
    HIFα is allowed to accumulate in the cell. It associates with HIFβ and this complex
    translocates to the nucleus and acts as a transcription factor binding to hypoxia
    response elements and upregulating oxygen-sensitive genes. These HIF-responsive
    genes include vascular endothelial growth factor (VEGF), platelet-derived growth
    factor (PDGF), transforming growth factor alpha (TGFα), glucose transporter-1
    (GLUT1), carbonic anhydrase IX (CA-IX), erythropoietin (EPO), and others. Examples
    of selected receptors are given, including VEGF receptor (VEGFR), PDGF receptor
    (PDGFR), and the receptor for TNFα and epidermal growth factor receptor (EGFR).
    Shown is the downstream signaling for one of these receptors, VEGFR, including
    through the PI3 kinase (PI3K)/AKT/mTOR, p38 MAP kinase (p38MAPK), and RAS/RAF/MEK/ERK
    pathways. Examples of agents (including pazopanib) that impact on this cascade
    are given, and where they act on the pathway is shown.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BRAF
  - EPAS1
  - MAPK3
  - SLC2A1
  - ARNTL
  - RAF1
  - BNIP3
  - HIF1A
  - KRAS
  - AKT3
  - VEGFC
  - AKT2
  - CA9
  - EGFR
  - EPO
  - MAPK1
  - ARAF
  - ARNT2
  - PDGFB
  - MAP2K2
  - HRAS
  - PDGFD
  - ARNT
  - AKT1
  - PIK3R6
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PDGFA
  - PDGFRA
  - HIF3A
  - PDGFC
  - PDGFRB
  - PIK3CA
  - PIK3R5
  - VEGFB
  - NRAS
  - VEGFA
  - MAPK14
  - MAP2K1
  - MTOR
  - VEGFD
  - PGF
  - MAPK12
  - FLT1
  - MAPK9
  - MAPK13
  - MAPK11
  - VHL
  - TGFA
  - MAPK8
  - KDR
  - FLT4
  - MAPK10
  - Temsirolimus
  - Pazopanib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: GLUT1
  symbol: GLUT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: BNIP3
  symbol: BNIP3
  source: hgnc_symbol
  hgnc_symbol: BNIP3
  entrez: '664'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CA-IX
  symbol: CAIX
  source: hgnc_alias_symbol
  hgnc_symbol: CA9
  entrez: '768'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EPO
  symbol: EPO
  source: hgnc_symbol
  hgnc_symbol: EPO
  entrez: '2056'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: HIFB
  symbol: HIF_beta
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: HIFB
  symbol: HIF_beta
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: HIFB
  symbol: HIF_beta
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: VHL
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: TGFa
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Pazopanib
  source: MESH
  identifier: C516667
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
